Peter Palese

Mount Sinai School of Medicine - Department of Microbiology

SCHOLARLY PAPERS

2

DOWNLOADS

278

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Intranasal SARS-CoV-2 Omicron Variant Vaccines Elicit Humoral and Cellular Mucosal Immunity in Mice

Number of pages: 36 Posted: 11 Jul 2023
Stefan Slamanig, Irene Gonzalez-Dominguez, Lauren Chang, Nicholas Lemus, Tsoi Ying Lai, Jose L. Martinez, Victoria Dolange, Adam Abdeljawad, Shreyas Kowdle, Moataz Noureddine, Gagandeep Singh, Gagandeep Singh, Benhur Lee, Adolfo Garcia-Sastre, Florian Krammer, Michael Schotsaert, Peter Palese and Weina Sun
Mount Sinai School of Medicine - Department of Microbiology, Mount Sinai School of Medicine - Department of Microbiology, National Institutes of Health - Vaccine Research Center, Mount Sinai School of Medicine - Department of Microbiology, Mount Sinai School of Medicine - Department of Microbiology, Mount Sinai School of Medicine - Department of Microbiology, Mount Sinai School of Medicine - Department of Microbiology, Mount Sinai School of Medicine - Department of Microbiology, Mount Sinai School of Medicine - Department of Microbiology, Mount Sinai School of Medicine - Department of Microbiology, Mount Sinai School of Medicine - Department of Microbiology, Mount Sinai School of Medicine - Department of Microbiology, Mount Sinai School of Medicine - Department of Microbiology, QBI Coronavirus Research Group (QCRG), Icahn School of Medicine at Mount Sinai - Department of Microbiology, Mount Sinai Health System - Department of Microbiology, Mount Sinai School of Medicine - Department of Microbiology and Mount Sinai School of Medicine - Department of Microbiology
Downloads 224 (270,611)

Abstract:

Loading...

COVID-19, mucosal immune response, low cost vaccine platform, variant vaccine, NDV vector, mRNA vaccine, prime-pull vaccination

2.

Safety and Immunogenicity of an Egg-Based Inactivated Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomized, Placebo-Controlled, Phase 1/2 Trial in Vietnam

Number of pages: 28 Posted: 10 Feb 2022
Dang Duc Anh, Thiem Dinh Vu, Ha Hai Vu, Van Thanh Ta, Anh Thi Van Pham, Mai Thi Ngoc Dang, Be Van Le, Thai Huu Duong, Duoc Van Nguyen, Saranath Lawpoolsri, Pailinrut Chinwangso, Jason S. McLellan, Ching-Lin Hsieh, Adolfo Garcia-Sastre, Peter Palese, Weina Sun, Jose L. Martinez, Irene Gonzalez-Dominguez, Stefan Slamanig, Juan Manuel Carreño, Johnstone Tcheou, Florian Krammer, Ariel Raskin, Huong Minh Vu, Thang Cong Tran, Huong Mai Nguyen, Laina D. Mercer, Rama Raghunandan, Manjari Lal, Jessica A. White, Richard Hjorth, Bruce L. Innis and Rami Scharf
National Institute of Hygiene and Epidemiology, National Institute of Hygiene and Epidemiology, affiliation not provided to SSRN, Hanoi Medical University, Hanoi Medical University, Hanoi Medical University, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Mahidol University, Center of Excellence for Biomedical and Public Health Informatics (BIOPHICS), University of Texas at Austin - Department of Molecular Biosciences, affiliation not provided to SSRN, QBI Coronavirus Research Group (QCRG), Mount Sinai School of Medicine - Department of Microbiology, Mount Sinai School of Medicine - Department of Microbiology, Mount Sinai School of Medicine - Department of Microbiology, Mount Sinai School of Medicine - Department of Microbiology, Mount Sinai School of Medicine - Department of Microbiology, affiliation not provided to SSRN, affiliation not provided to SSRN, Icahn School of Medicine at Mount Sinai - Department of Microbiology, affiliation not provided to SSRN, affiliation not provided to SSRN, PATH, PATH, PATH, PATH, PATH, PATH, PATH, PATH and PATH
Downloads 54 (735,365)

Abstract:

Loading...

SARS-CoV-2, COVID-19, Newcastle disease virus, Egg-based vaccine